Sanofi links with Evotec to tap stem cells for diabetes care – Reuters
Reuters |
Sanofi links with Evotec to tap stem cells for diabetes care
Reuters French drugmaker Sanofi is linking with Evotec to develop stem cell-based treatments for diabetes, under a deal that could earn the German biotech firm more than 300 million euros ($327 million). Sanofi, a leading supplier of diabetes care, said on … Sanofi and Evotec Align Forces to Develop Next Generation Therapies in Diabetes Sanofi, Evotec Enter New Research Collaboration to Discover and Develop Novel … |
